Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CIN-110 by CinFina Pharma for Obesity: Likelihood of Approval
CIN-110 is under clinical development by CinFina Pharma and currently in Phase I for Obesity. According to GlobalData, Phase I...